Jade Biosciences, Inc.

Jade Biosciences, Inc.verified

JBIO

Price:

$15.34

Market Cap:

$500.48M

Jade Biosciences, Inc. operates as a biotechnology enterprise, primarily focused on pioneering superior therapeutic solutions for significant unmet medical requirements in autoimmune disorders. Its leading development candidate, JADE-001, specifically targets the anti-A PRoliferation-Inducing Ligand (APRIL) pathway, aiming to treat immunoglobulin A (IgA) nephropathy. Clinical trials for JADE-001 are slated to commence in the latter half of 2025, with initial results projected for the first half of 2026. Beyond this lead asset, the company's robust pipeline includes two preclinical antibody programs, JADE-002 and JADE-003.

Industry

Biotechnology

IPO Date

2025-04-29

Stock Exchange

NASDAQ

Ticker

JBIO

The Enterprise Value as of June 2026 (TTM) for Jade Biosciences, Inc. (JBIO) is 446.07M

According to Jade Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 446.07M. This represents a change of -15.76% compared to the average of 529.51M of the last 4 quarters.

Jade Biosciences, Inc. (JBIO) Historical Enterprise Value (quarterly & annually)

How has JBIO Enterprise Value performed in the past?

The mean historical Enterprise Value of Jade Biosciences, Inc. over the last ten years is 415.71M. The current 446.07M Enterprise Value has changed 10.63% with respect to the historical average. Over the past ten years (40 quarters), JBIO's Enterprise Value was at its highest in in the December 2025 quarter at 1.00B. The Enterprise Value was at its lowest in in the June 2024 quarter at 18.50M.

Quarterly (TTM)
Annual

Average

415.71M

Median

474.44M

Minimum

42.41M

Maximum

695.72M

Jade Biosciences, Inc. (JBIO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Jade Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 834.17%

Maximum Annual Enterprise Value = 695.72M

Minimum Annual Increase = -92.60%

Minimum Annual Enterprise Value = 42.41M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025396.17M834.17%
202442.41M-92.60%
2023573.07M-17.63%
2022695.72M197.10%
2021234.18M-57.63%

Jade Biosciences, Inc. (JBIO) Average Enterprise Value

How has JBIO Enterprise Value performed in the past?

The current Enterprise Value of Jade Biosciences, Inc. (JBIO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

337.22M

5-year avg

388.31M

10-year avg

415.71M

Jade Biosciences, Inc. (JBIO) Enterprise Value vs. Peers

How is JBIO’s Enterprise Value compared to its peers?

Jade Biosciences, Inc.’s Enterprise Value is greater than Silence Therapeutics plc (310.47M), greater than Lyell Immunopharma, Inc. (263.73M), greater than Aldeyra Therapeutics, Inc. (56.68M), greater than Kyverna Therapeutics, Inc. (329.49M), greater than Contineum Therapeutics, Inc. Class A Common Stock (430.95M), greater than Genelux Corporation (104.57M), less than XOMA Royalty Corp. (554.36M), greater than Tectonic Therapeutic, Inc. (339.10M), greater than AC Immune S.A. (171.83M),

Build a custom stock screener for Jade Biosciences, Inc. (JBIO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jade Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Jade Biosciences, Inc. (JBIO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Jade Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Jade Biosciences, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Jade Biosciences, Inc. (JBIO)?

What is the 3-year average Enterprise Value for Jade Biosciences, Inc. (JBIO)?

What is the 5-year average Enterprise Value for Jade Biosciences, Inc. (JBIO)?

How does the current Enterprise Value for Jade Biosciences, Inc. (JBIO) compare to its historical average?